TY - JOUR
AU - Alsfouk, Aisha
AB -  Abstract Cyclin-dependent kinase 9 (CDK9) plays a vital role in transcription through regulation of short-lived anti-apoptotic genes required for cancer cell survival. Therefore, targeting CDK9 with small molecule inhibitors has emerged as a potential cancer therapy. This article reviews the most recent CDK9 patent literature (2012–2020) related to small molecule inhibitors in cancer along with their selectivity profile and biological results in preclinical studies. 
TI - Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
JF - Journal of Enzyme Inhibition & Medicinal Chemistry
DO - 10.1080/14756366.2021.1890726
DA - 2021-01-01
UR - https://www.deepdyve.com/lp/taylor-francis/small-molecule-inhibitors-of-cyclin-dependent-kinase-9-for-cancer-j3QBSExVAK
SP - 693
EP - 706
VL - 36
IS - 1
DP - DeepDyve
ER -